Harvard Bioscience
HBIO
HBIO
93 hedge funds and large institutions have $177M invested in Harvard Bioscience in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 94 → 93 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Holders
93
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.18M | |
| 2 | +$916K | |
| 3 | +$866K | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$577K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$468K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$1.48M | |
| 3 | -$427K | |
| 4 |
Two Sigma Investments
New York
|
-$416K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$289K |